Fish & Richardson Trademark & Copyright Thoughts

NOVEMBER 13, 2020

7] If a branded company initiates an infringement action against a generic company within 45 days of receiving notice of ANDA submission, this triggers a 30-month stay during which FDA cannot issue a final approval for the ANDA. [8] If a branded company gets venue wrong, it risks a motion to dismiss for improper venue.

Branding 52

Branding Brands Branding Litigation 52

Bio Law Blog

APRIL 15, 2020

Generally, viruses penetrate a host cell, co-opt the host-cell machinery to replicate their genome, assemble new viruses and then escape the cell to spread the infection. Drug repurposing is being aggressively pursued by the biopharmaceutical industry. Antiviral drugs aim to interrupt some part of the viral life cycle.

Copying 40

Copying Designs Design 40

Fish & Richardson Trademark & Copyright Thoughts

JUNE 4, 2021

It exempts companies from certain acts of patent infringement by creating the so-called safe harbor that allows them to use a “patented invention” “solely for uses reasonably related to the development and submission of information [to the FDA].” [7] 2d at 1265 (quoting Eli Lilly & Co. Statutory Background.

Invention 52

Invention Patent Marketing Marketing 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Several other companies have also announced plans to pursue interchangeable status for biosimilar products. Consistent with this, as shown below in Table 2, numerous companies have publicly announced the submission and/or acceptance of new biosimilar BLAs. Eli Lilly). Biosimilar Approvals and Launches in 2021. Lucentis ®.

Litigation 52

Litigation Settlement Patent Marketing 52

Patently-O

DECEMBER 11, 2023

Assume also that the company selling the software doesn’t provide specific instructions on how to use the five features, thus taking potential liability outside the realm of § 271(b). Kelley Co. , On a related note, in Eli Lilly & Co. citing Eli Lilly and Co. 3d 1538 (Fed.

Patent 44

Patent Technology Litigation Reporting 44

SpicyIP

DECEMBER 30, 2023

[ This post has been co-authored with Jyotpreet Kaur, Tejaswini Kaushal, Praharsh Gour, and Swaraj Barooah ]. RDB and Co. Controller of Patents and Designs and Raytheon Company v. In another judgement, Raytheon Company v. The judgement in the Raytheon Company case was passed by a Single Judge Bench of Justice Prathiba M.

IP 124

IP Copyright Trademark Intellectual Property 124

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

As of the March 23, 2020 transition, however, all “biological product” applications previously approved under the FD&C Act were “deemed” approved under the PHS Act, and companies can now seek biosimilars and interchangeables of these biological products. As noted above, companies are already taking advantage of these new designations.

Settlement 52

Settlement Litigation Marketing Marketing 52